Key Developments: Hofseth Biocare ASA (HOFBC.OL)

HOFBC.OL on Oslo Stock Exchange

2.40NOK
4 Mar 2015
Change (% chg)

kr-0.08 (-3.23%)
Prev Close
kr2.48
Open
kr2.48
Day's High
kr2.48
Day's Low
kr2.38
Volume
24,169
Avg. Vol
277,857
52-wk High
kr5.44
52-wk Low
kr2.30

Search Stocks

Latest Key Developments (Source: Significant Developments)

Nattopharma launches MenaQ7 and Omegot dietary supplement with Hofseth Biocare
Wednesday, 25 Feb 2015 04:00am EST 

Nattopharma ASA:NattoPharma launches MenaQ7 and OmegoT dietary supplement together with Hofseth Biocare.  Full Article

Hofseth Biocare ASA to sign distribution agreement in Japan
Friday, 6 Feb 2015 09:45am EST 

Hofseth Biocare ASA:Starts selling in the Japanese market.Is in talks on a distribution agreement regarding HBC products in Japan.Negotiations are in final phase with one concrete partner and are expected to be in place by the end of Q1.  Full Article

Hofseth Biocare receives orders from European customer
Tuesday, 30 Dec 2014 03:02am EST 

Hofseth Biocare ASA:Hofseth BioCare has received an order from a European customer on all HBCs main products.Says will supply finished consumer products on salmon oil, protein and calcium.The products will be marketed and sold together as a "whole fish" concept, where it all three products is sold in one SKU.Says first orders for Germany has a value of 11.3 million Norwegian crowns ($1.52 million) and will be delivered in Q1 2015.  Full Article

Hofseth Biocare ASA signs new agreements on fresh salmon oil and have installed new steam boiler
Thursday, 4 Dec 2014 02:55am EST 

Hofseth Biocare ASA:Signs new agreements on fresh salmon oil and have installed new steam boiler.Contracts are signed with two European retail chain customers and have a minimum annual contract value of 40 million Norwegian crowns.Says first deliveries will take place during Q1 2015.Says has also installed new steam boiler at Midsund plant during November.  Full Article

Hofseth Biocare receives order for salomon protein ProGo
Monday, 24 Nov 2014 07:45am EST 

Hofseth Biocare ASA:Says has received an order for HBCs salomon protein ProGo from an asian customer.First deliveries are expected to be in December 2014 or January 2015.  Full Article

Hofseth Biocare ASA in final negotiations on two agreements worth NOK 40 mln
Wednesday, 19 Nov 2014 05:05am EST 

Hofseth Biocare ASA:Says is in final negotiations on two agreements of fresh encapsulated salmon oil.Minimum annual value of contracts is 40 million Norwegian crowns.The contracts could lead to the first deliveries in Q1 or Q2 2015.Says has also received confirmation regarding launch in USA under private label from April 2015.  Full Article

Hofseth Biocare ASA gives future 2015 outlook
Friday, 14 Nov 2014 02:00am EST 

Hofseth Biocare ASA:Says increased customer base will provide improved revenues in 2015.Says HBC expects large volumes in pet nutrition in 2015 and 2016.Says expects higher turnover and better margins in 2015.  Full Article

Hofseth Biocare: new protein for endurance sports
Thursday, 13 Nov 2014 02:01am EST 

Hofseth Biocare ASA:Launches new protein for endurance sports.  Full Article

Hofseth Biocare ASA signs distribution of Salmon Protein Hydrolysate with Aceto
Friday, 17 Oct 2014 04:06am EDT 

Hofseth Biocare ASA:Says Hofseth Biocare ASA signs distribution of Salmon Protein Hydrolysate with Aceto Health Ingredients GmbH for the European market.Says the agreement is the largest of its kind HBC has signed and will give revenues in 2015 and onward.Says agreement includes exclusive rights for Aceto to distribute ProGo as a human nutrition ingredient in EU and Swiss market.Says agreement is signed conditional to sales performance and market efforts by Aceto.Says agreement strengthens HBC sales in European market through Aceto's sales force.  Full Article

Hofseth Biocare completes clinical study on salmon protein
Monday, 6 Oct 2014 07:20am EDT 

Hofseth Biocare ASA:Says completes clinical study on salmon protein, showing strong results on treatment of anemia and obesity.Says results from study are significant and show strong increase in hemoglobin and decreased BMI (Body Mass Index), using HBCs salmon protein hydrolysate.Says final report on study will be published early 2015.  Full Article

BRIEF-Hofseth Biocare Q4 EBIT loss widens to NOK 28.2 million

* Q4 operating revenues 9.1 million Norwegian crowns ($1.20 million) versus 28.0 million crowns in Q4 of 2013

Search Stocks